Supporting mental health needs in rural areas
- April 20, 2023
- The REACH Institute
- ADHD, Anxiety, Child mental health, Depression, Eating disorders, High-risk children & youth, LGBTQIA, Parents, Patient communication, Pediatric primary care
Rural healthcare providers can be overwhelmed—and understaffed with specialists. Discover how REACH inspired Elizabeth Wallis, M.D., to build a community to support her patients.
ADHD medication “holidays”?
- June 13, 2022
- The REACH Institute
- ADHD, Medication Parents,
As summer rolls around, families may ask whether their children can have a “holiday” from their psychoactive medication, especially for attention-deficit hyperactivity disorder (ADHD). We asked Lawrence Amsel, MD, MPH, a REACH faculty member and associate professor of psychiatry at Columbia University, to lay out the pros and cons.
Is it ADHD? Or something else?
- December 14, 2022
- The REACH Institute
- ADHD, Assessment & screening, Child mental health
Attention-deficit hyperactivity disorder (ADHD) is one of the most common behavioral health disorders, affecting approximately 9% of all children and adolescents. About 75% of pediatric patients with ADHD have comorbid mental health conditions, ranging from oppositional-defiant disorder to anxiety and mood disorders.
What is a busy clinician to do? How do you discern whether a child who is, say, having difficulty focusing at school and at home has ADHD, anxiety, both, or something else?
IEP and 504 school accommodations for mental health needs
- July 12, 2022
- The REACH Institute
- ADHD, Anxiety, Child mental health Depression,
Children with mental health diagnoses may need special accommodations in order to succeed in school. Patients with attention-deficit hyperactivity disorder (ADHD) or autism come immediately to mind. However, children with depression and anxiety disorders may also struggle in the classroom.
Pediatric primary care providers (PCPs) and therapists can help families get the school accommodations their children need. Mark Wolraich, MD, REACH faculty member and retired professor of pediatrics at the University of Oklahoma Health Sciences Center, emphasizes that children are best served when professionals take a team approach to mental health care.
New treatments for ADHD
- January 21, 2022
- The REACH Institute
- ADHD Medication,
Newer treatments approved by the Food and Drug Administration (FDA) for pediatric patients with attention-deficit/hyperactivity disorder (ADHD) include two medications that address some of the common issues families have with standard stimulant treatments. Another development is use of devices to manage ADHD symptoms.
Getting smarter about child mental health
- June 12, 2018
- The REACH Institute
- ADHD, Child mental health Medication,
“For these straightforward cases, when you can identify uncomplicated ADHD in patients without co-occuring depression or anxiety – well, everyone in primary care should be able to do this.”
Categories
- ADHD
- Anti-racism
- Anxiety
- Assessment & screening
- Child mental health
- Coding
- Cognitive behavioral therapy
- College transition
- Culturally responsive
- Depression
- Eating disorders
- Foster care
- Grief
- High-risk children & youth
- LGBTQIA
- Medication
- Parents
- Patient communication
- Pediatric primary care
- School refusal
- Sleep disorders
- Suicide
- Trauma
- Show All Categories
Dates
Register for courses
“This is the first conference I’ve been to where I felt like the entire weekend will impact my practice I think that is due to the engaging, hands-on and fun format. It kept me engaged throughout. Also, I feel like the materials we received are sending me out into the world armed with the tools I need to put the information I learned into practice.”